Epidermal Growth Factor Receptor Mutation Status and Rad51 Determine the Response of Glioblastoma to Multimodality Therapy With Cetuximab, Temozolomide, and Radiation
Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2013.00013
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2013
Authors
Publisher
Frontiers Media SA